KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Change in Inventory (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Change in Inventory for 8 consecutive years, with $10000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 100.3% to $10000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $998000.0 through Dec 2025, up 118.58% year-over-year, with the annual reading at $998000.0 for FY2025, 118.58% up from the prior year.
  • Change in Inventory hit $10000.0 in Q4 2025 for Adaptive Biotechnologies, down from $1.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $6.6 million in Q1 2023 to a low of -$4.0 million in Q4 2023.
  • Historically, Change in Inventory has averaged $142350.0 across 5 years, with a median of -$27500.0 in 2023.
  • Biggest five-year swings in Change in Inventory: soared 6511.11% in 2021 and later crashed 721.61% in 2024.
  • Year by year, Change in Inventory stood at $1.0 million in 2021, then plummeted by 393.51% to -$3.0 million in 2022, then crashed by 31.3% to -$4.0 million in 2023, then rose by 14.96% to -$3.4 million in 2024, then soared by 100.3% to $10000.0 in 2025.
  • Business Quant data shows Change in Inventory for ADPT at $10000.0 in Q4 2025, $1.3 million in Q3 2025, and -$95000.0 in Q2 2025.